$SCWO
374Water Inc Stock $scwo

$scwo Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000165495422002303 Filed on March 01, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$14.50K	$48.10K	$60.00K
YoY Change	-75.83%	-46.56%	200.0%
Cost Of Revenue		$0.00	$10.00K
YoY Change		-100.0%
Gross Profit		$48.10K	$50.00K
YoY Change		-31.29%
Gross Profit Margin		100.0%	83.33%
Selling, General & Admin	$581.7K	$1.440M	-$160.0K
YoY Change	-463.56%	4700.0%	-366.67%
% of Gross Profit		2993.76%	-320.0%
Research & Development	$105.2K	$375.0K
YoY Change		549.77%
% of Gross Profit		779.69%
Depreciation & Amortization	$29.74K	$50.00K	$0.00
YoY Change
% of Gross Profit		103.95%	0.0%
Operating Expenses	$686.9K	$3.214M	-$180.0K
YoY Change	-481.63%	3726.68%	-300.0%
Operating Profit		-$3.166M	$230.0K
YoY Change		27045.74%
Interest Expense	$320.00	$0.00	$50.00K
YoY Change	-99.36%		-600.0%
% of Operating Profit			21.74%
Other Income/Expense, Net	$330.00	$1.400K	$50.00K
YoY Change	-99.34%	-97.31%
Pretax Income	-$671.8K	-$3.165M	$330.0K
YoY Change	-303.57%	-7945.42%	-466.67%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income			0.0%
Net Earnings	-$671.8K	-$3.165M	$330.0K
YoY Change	-303.57%	-7945.42%	-466.67%
Net Earnings / Revenue	-4633.03%	-6579.23%	550.0%
Basic Earnings Per Share
Diluted Earnings Per Share	-$7.146K	-$33.62K	$0.01
COMMON SHARES
Basic Shares Outstanding	122.8M shares	94.00M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.13M	$11.13M	$70.00K
YoY Change	15801.69%	15800.0%	250.0%
Cash & Equivalents	$11.13M		$71.80K
Short-Term Investments
Other Short-Term Assets	$218.5K	$220.0K	$0.00
YoY Change			-100.0%
Inventory	$0.00
Prepaid Expenses	$218.5K		$0.00
Receivables	$0.00	$0.00	$30.00K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$11.35M	$11.35M	$103.1K
YoY Change	10905.29%	11250.0%	157.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$959.00	$0.00	$403.00
YoY Change	137.97%
Goodwill
YoY Change
Intangibles	$1.063M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$34.74K	$30.00K	$0.00
YoY Change
Total Long-Term Assets	$1.064M	$1.060M	$678.00
YoY Change	156804.87%
TOTAL ASSETS
Total Short-Term Assets	$11.35M	$11.35M	$103.1K
Total Long-Term Assets	$1.064M	$1.060M	$678.00
Total Assets	$12.41M	$12.41M	$103.8K
YoY Change	11858.21%	12310.0%	159.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$62.98K	$60.00K	$80.00K
YoY Change	-21.28%	-25.0%	-20.0%
Accrued Expenses
YoY Change
Deferred Revenue	$0.00		$0.00
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$86.37K	$90.00K	$92.56K
YoY Change	-6.68%	0.0%	-7.44%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$86.37K	$90.00K	$92.56K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$86.37K	$90.00K	$92.56K
YoY Change	-6.68%	0.0%	-77.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.160M		$4.593K
YoY Change	-68900.67%
Common Stock	$12.53K		$6.241K
YoY Change	100.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$12.33M	$12.33M	$11.25K
YoY Change
Total Liabilities & Shareholders Equity	$12.41M	$12.41M	$103.8K
YoY Change	11858.21%	12310.0%	159.52%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$671.8K	-$3.165M	$330.0K
YoY Change	-303.57%	-7945.42%	-466.67%
Depreciation, Depletion And Amortization	$29.74K	$50.00K	$0.00
YoY Change
Cash From Operating Activities	-$787.4K	-$1.841M	$270.0K
YoY Change	-391.61%	-2942.77%	-775.0%
INVESTING ACTIVITIES
Capital Expenditures	$1.130K	$1.190K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$19.83K	$30.00K	$0.00
YoY Change
Cash From Investing Activities	$20.96K	$28.35K	$0.00
YoY Change		-10407.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$5.000M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.050M	$12.87M	-330.0K
YoY Change	-1630.3%	627189.52%	-1750.0%
NET CHANGE
Cash From Operating Activities	-787.4K	-$1.841M	270.0K
Cash From Investing Activities	20.96K	$28.35K	0.000
Cash From Financing Activities	5.050M	$12.87M	-330.0K
Net Change In Cash	4.284M	$11.06M	-60.00K
YoY Change	-7239.33%	16521.64%	200.0%
FREE CASH FLOW
Cash From Operating Activities	-$787.4K	-$1.841M	$270.0K
Capital Expenditures	$1.130K	$1.190K
Free Cash Flow	-$788.5K	-$1.842M
YoY Change		-2944.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11250	USD
CY2021	dei	Auditor Location AuditorLocation	Palm Beach Gardens, Florida
CY2020Q4	us-gaap	Cash Cash	71799	USD
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	31330	USD
CY2021Q4	scwo	Advances From Stockholders AdvancesFromStockholders	0	USD
CY2020Q4	scwo	Advances From Stockholders AdvancesFromStockholders	15108	USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	scwo	Preferred Stock Liquidation Preferences PreferredStockLiquidationPreferences	409005	USD
CY2021	us-gaap	Revenues Revenues	48100	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	14241	USD
CY2021	scwo	Revenue From Contracts With Customer Excluding Assessed Tax RevenueFromContractsWithCustomerExcludingAssessedTax	48100	USD
CY2020	scwo	Revenue From Contracts With Customer Excluding Assessed Tax RevenueFromContractsWithCustomerExcludingAssessedTax	72329	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	375032	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	57718	USD
CY2021	us-gaap	Production Costs ProductionCosts	1399833	USD
CY2020	us-gaap	Production Costs ProductionCosts	0	USD
CY2021	us-gaap	Professional Fees ProfessionalFees	343862	USD
CY2020	us-gaap	Professional Fees ProfessionalFees	8791	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1095381	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17483	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	3214108	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	83992	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-3166008	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-11663	USD
CY2021	scwo	Award Income AwardIncome	0	USD
CY2020	scwo	Award Income AwardIncome	52000	USD
CY2021	us-gaap	Interest Income Operating InterestIncomeOperating	1066	USD
CY2020	us-gaap	Interest Income Operating InterestIncomeOperating	0	USD
CY2021	us-gaap	Other Income OtherIncome	334	USD
CY2020	us-gaap	Other Income OtherIncome	0	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1400	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	52000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3164608	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	40337	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3164608	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	40337	USD
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.03
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.00
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94002888	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62410452	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-35744	USD
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	6329	USD
CY2020	scwo	Accretion Of Stock Based Compensation AccretionOfStockBasedCompensation	328	USD
CY2020	us-gaap	Profit Loss ProfitLoss	40337	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11250	USD
CY2021	scwo	Accretion Of Stock Based Compensation AccretionOfStockBasedCompensation	204217	USD
CY2021	scwo	Issuance Of Stock Warrants For Development Of Product IssuanceOfStockWarrantsForDevelopmentOfProduct	1399833	USD
CY2021	scwo	Recapitalization Of The Company Amount RecapitalizationOfTheCompanyAmount	-84225	USD
CY2021	scwo	Series D Preferred Stock Issued For Cash Amount SeriesDPreferredStockIssuedForCashAmount	6601745	USD
CY2021	scwo	Exercised Option And Warrants Amount ExercisedOptionAndWarrantsAmount	1285344	USD
CY2021	scwo	Issuance Of Common Stock For License Rights Amount IssuanceOfCommonStockForLicenseRightsAmount	1073529	USD
CY2021	scwo	Conversion Of Convertible Preferred Shares Into Common Stock Amount ConversionOfConvertiblePreferredSharesIntoCommonStockAmount	0	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5000000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3164608	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12327085	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3164608	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	40337	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	911	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	328	USD
CY2021	scwo	Adjustment For Common Stock Issued For Services AdjustmentForCommonStockIssuedForServices	0	USD
CY2020	scwo	Adjustment For Common Stock Issued For Services AdjustmentForCommonStockIssuedForServices	6329	USD
CY2021	scwo	Warrant Issued For Product Development Agreement WarrantIssuedForProductDevelopmentAgreement	1399833	USD
CY2020	scwo	Warrant Issued For Product Development Agreement WarrantIssuedForProductDevelopmentAgreement	0	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	32330	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-31330	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	47488	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-238450	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	0	USD
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	22190	USD
CY2020	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	696	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1840950	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	64759	USD
CY2021	scwo	Proceeds From Reverse Acquisition ProceedsFromReverseAcquisition	113760	USD
CY2020	scwo	Proceeds From Reverse Acquisition ProceedsFromReverseAcquisition	0	USD
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	0	USD
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-275	USD
CY2021	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	84225	USD
CY2020	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-275	USD
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-15108	USD
CY2020	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	2052	USD
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	6601745	USD
CY2020	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	42845	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1242499	USD
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12871981	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2052	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	11059376	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	66536	USD
CY2021	scwo	Cash Beginning Of Year Cash-BeginningOfYear	71799	USD
CY2020	scwo	Cash Beginning Of Year Cash-BeginningOfYear	5263	USD
CY2021	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	11131175	USD
CY2020	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	71799	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2021	scwo	Issuance Of Common Stock For License Rights IssuanceOfCommonStockForLicenseRights	1073529	USD
CY2020	scwo	Issuance Of Common Stock For License Rights IssuanceOfCommonStockForLicenseRights	0	USD
CY2021	scwo	Accounts Payable Settled With Stock Option AccountsPayableSettledWithStockOption	50000	USD
CY2020	scwo	Accounts Payable Settled With Stock Option AccountsPayableSettledWithStockOption	0	USD
CY2021	scwo	Net Liabilities Assumed In Reverse Acquisitioncash NetLiabilitiesAssumedInReverseAcquisitioncash	29536	USD
CY2020	scwo	Net Liabilities Assumed In Reverse Acquisitioncash NetLiabilitiesAssumedInReverseAcquisitioncash	0	USD
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	14483	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	0	USD
CY2021	us-gaap	Accounts Receivable Sale AccountsReceivableSale	1000	USD
CY2020	us-gaap	Accounts Receivable Sale AccountsReceivableSale	0	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-46150	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	0	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-83094	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	0	USD
CY2021	scwo	Net Liability Assumed NetLiabilityAssumed	-84225	USD
CY2020	scwo	Net Liability Assumed NetLiabilityAssumed	0	USD
CY2021Q2	scwo	Shares Issued To Former Holder SharesIssuedToFormerHolder	62410452	shares
CY2021Q2	scwo	Merger Effect Description MergerEffectDescription	Immediately following the Merger, 374Water changed its name to 374Water Systems Inc and PowerVerde changed its name to 374Water, Inc. After the Merger, the former 374Water stockholders own 65.8% of 374Water Inc’s issued and outstanding common stock and 53.8% of 374Water Inc.’s issued and outstanding voting stock which includes the Preferred Stock.
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	375032	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	57718	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, fair value of intangible assets, useful lives of intangible assets, capital raise transactions, and valuation allowance against deferred tax assets.</p>
CY2021Q4	scwo	Working Capital WorkingCapital	11263270	USD
CY2020Q4	scwo	Working Capital WorkingCapital	10572	USD
CY2021	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	6551745	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	5000000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3160015	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3164608	USD
CY2021	scwo	Net Cash Provided By Used In Operating Activity NetCashProvidedByUsedInOperatingActivity	1840950	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	0	USD
CY2021Q4	scwo	Intangible Assets Additions IntangibleAssetsAdditions	1108270	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	45415	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1062855	USD
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	45415	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	63149	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	63149	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	63149	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	63149	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	63149	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	712369	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1028114	USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	436782	shares
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	6551691	USD
CY2021	scwo	Liability For Preferred Stock Shares LiabilityForPreferredStockShares	50000	USD
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33203512	shares
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5000000	USD
CY2021	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2500000	shares
CY2021	scwo	Common Stock Shares Issues For Cash CommonStockSharesIssuesForCash	4958833	shares
CY2021	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	-379817	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	40000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2465183	shares
CY2021Q2	scwo	Number Of Warrant Purchase NumberOfWarrantPurchase	3783333	shares
CY2021Q2	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.30
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.37
CY2021Q2	scwo	Aggregate Fair Value Of Warrant AggregateFairValueOfWarrant	1399833	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1250000	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.50
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	437500	USD
CY2021Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	2.85
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	950000	shares
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.11
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	690500	USD
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y5M8D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	950000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.11
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	690500	USD
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y5M8D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5033333	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.85
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	4733333	shares
CY2021	scwo	Weighted Average Exercise Price Exercised WeightedAverageExercisePriceExercised	0.26
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1250000	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.50
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y11M15D
CY2021Q4	scwo	Advances From Stockholders AdvancesFromStockholders	0	USD
CY2020Q4	scwo	Advances From Stockholders AdvancesFromStockholders	15108	USD
CY2021	us-gaap	Related Party Costs RelatedPartyCosts	43205	USD
	us-gaap	Related Party Costs RelatedPartyCosts	0	USD
CY2021Q4	us-gaap	Due From Related Parties DueFromRelatedParties	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	208742	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	USD
CY2021Q4	scwo	Deferred Tax Assets Startup Cost DeferredTaxAssetsStartupCost	83710	USD
CY2020Q4	scwo	Deferred Tax Assets Startup Cost DeferredTaxAssetsStartupCost	0	USD
CY2021Q4	scwo	Other Intangibles OtherIntangibles	10339	USD
CY2020Q4	scwo	Other Intangibles OtherIntangibles	0	USD
CY2021Q4	scwo	Other Accruals OtherAccruals	1875	USD
CY2020Q4	scwo	Other Accruals OtherAccruals	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	17423	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1764	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	381112	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	703211	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1764	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	703083	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1764	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	128	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-128	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	128	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1764	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.2100	pure
CY2019	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.2100	pure
CY2020	scwo	Income Tax Rate Reconciliation Change In State Tax IncomeTaxRateReconciliationChangeInStateTax	0	pure
CY2019	scwo	Income Tax Rate Reconciliation Change In State Tax IncomeTaxRateReconciliationChangeInStateTax	0	pure
CY2020	scwo	Income Tax Reconciliation Change In Valuation Allowance IncomeTaxReconciliationChangeInValuationAllowance	-0.2216	pure
CY2019	scwo	Income Tax Reconciliation Change In Valuation Allowance IncomeTaxReconciliationChangeInValuationAllowance	0.1911	pure
CY2020	scwo	Income Tax Reconciliation Permanent Differences IncomeTaxReconciliationPermanentDifferences	-0.1226	pure
CY2019	scwo	Income Tax Reconciliation Permanent Differences IncomeTaxReconciliationPermanentDifferences	0	pure
CY2020	scwo	Income Tax Reconciliation State Taxes IncomeTaxReconciliationStateTaxes	0.0198	pure
CY2019	scwo	Income Tax Reconciliation State Taxes IncomeTaxReconciliationStateTaxes	0.0550	pure
CY2020	scwo	Income Tax Reconciliation Other IncomeTaxReconciliationOther	0.1144	pure
CY2019	scwo	Income Tax Reconciliation Other IncomeTaxReconciliationOther	-0.4561	pure
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1700000	USD

Files In Submission

Name	View Source	Status
0001654954-22-002303-index-headers.html	Edgar Link	pending
0001654954-22-002303-index.html	Edgar Link	pending
0001654954-22-002303.txt	Edgar Link	pending
0001654954-22-002303-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
scwo-20211231.xsd	Edgar Link	pending
scwo-20211231_cal.xml	Edgar Link	unprocessable
scwo-20211231_def.xml	Edgar Link	unprocessable
scwo-20211231_lab.xml	Edgar Link	unprocessable
scwo-20211231_pre.xml	Edgar Link	unprocessable
scwo_10-k.htm	Edgar Link	pending
scwo_10-kimg10.jpg	Edgar Link	pending
scwo_10-kimg11.jpg	Edgar Link	pending
scwo_10-kimg12.jpg	Edgar Link	pending
scwo_10-k_htm.xml	Edgar Link	completed
scwo_ex311.htm	Edgar Link	pending
scwo_ex312.htm	Edgar Link	pending
scwo_ex321.htm	Edgar Link	pending
scwo_ex322.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCWO
374Water Inc Stock $scwo

2021 Q4 Form 10-K Financial Statement

#000165495422002303 Filed on March 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCWO 374Water Inc Stock $scwo

2021 Q4 Form 10-K Financial Statement

#000165495422002303 Filed on March 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCWO
374Water Inc Stock $scwo